The Vanquish procedure is a minimally invasive procedure designed to ablate targeted prostate tissue. Performed under ultrasound guidance, the procedure deploys thermal water in the form of vapor (steam), transurethrally, to ablate targeted tissue in any zone of the prostate.
The following ICD-10 Diagnosis Code (Dx) may be associated with the Vanquish procedure. It is the provider’s responsibility to report diagnosis code(s) that most accurately describes the patient’s condition(s). Diagnosis codes in addition to a primary Dx code may also be reported. Verify accurate Dx coding requirements with the health plans. ICD-10 DESCRIPTOR C61 [...]
The following CPT code is associated with the Vanquish procedure. It is the provider’s responsibility to code to the highest level of specificity to report a patient’s condition for services rendered. Francis Medical encourages providers to verify appropriate coding and submit claims for the Vanquish procedure that are accurate based on the provider’s assessment of [...]
FACILITY CODING: HOSPITAL OUTPATIENT OR AMBULATORY SURGERY CENTER (ASC) HOSPITAL ASC CPT® Code Medicare APC APC Description APC Allowed Amount SI Allowed Amount SI 0582T 5377 Level 7 Urology and Related Services $13,479.22 J1 $10,892.79 J8 DEVICE CODE - HOSPITAL OUTPATIENT ONLY HCPCS Code Description C1889 Implantable/insertable, device not otherwise classified [...]
National relative value units (RVUs) are not established for Category III CPT codes. Because Category III CPT codes do not have established physician work and practice expense values, referencing an existing Category I CPT code(s) as a comparison can serve as a helpful proxy to describe the work, time, and complexity associated with performing [...]
Category III codes are common so many health plans, including Medicare, may allow submission of a cover letter in which you can identify a comparable procedure code and describe why you believe there are similarities in work, time, and complexity between the Vanquish procedure and the identified comparison procedure. You can also describe differences between [...]
A best practice when reporting a service using a new Category III CPT code can be to use the freeform field (box 19) of the claim form to list the identified comparison CPT code, including its 2026, geographically adjusted Medicare RVUs and allowed amount. This may be useful in helping the health plan to understand [...]
When submitting a claim using a Category III CPT Code, including for the Vanquish procedure, Medicare may request providers submit additional documentation through the Medicare Paperwork (PWK) process to be able to accurately adjudicate the claim. The PWK process will allow you to alert Medicare when submitting an electronic Part B claim that you’re also [...]
Francis Medical has created example materials, including sample letters, for illustrative purposes only. Sample materials are available on request from the Francis Medical Reimbursement team. Providers are solely responsible for preparing and submitting prior authorization requests and/or appeals through the health plans process and ensuring that the information included accurately reflects the patient's condition. Additionally, [...]
You may contact your health plan to confirm coverage and their medical necessity requirements. Medical Policies, Coverage Determination Guidelines, and Utilization Review Guidelines are developed by individual health plans for services and procedures, as needed, and are subject to change. Regardless of level of CPT coding, in the absence of written medical policy, medical necessity [...]
Vanquish procedure. In the absence of an NCD or LCD, individual Medicare Administrative Contractors (MACs) will determine if an item or service is “reasonable and necessary” on a claim-by-claim basis pursuant to Section 1862(a)(1)(A) of the Social Security Act.³
Yes, one of the benefits of the Vanquish procedure is that it destroys the targeted tissue while providing flexibility for future procedures should it become necessary.
Since this is a minimally invasive outpatient procedure, recovery times are typically relatively short. Your physician will provide more detailed information in your discharge instructions.
Side effects may occur and are usually minor and resolve over time. Common side effects observed in clinical studies include: blood in urine, urinary retention if catheter is removed too soon, sexual dysfunction, irritative urinary symptoms, post void dribbling, mild incontinence, and urethral discharge.
There are risks with any procedure and with anesthesia. Your doctor will discuss these risks with you. However, early clinical data supports the safety of the Vanquish procedure. In both the VAPOR 1 (n=15) and initial analysis of VAPOR 2 (n=110) studies: There were no serious adverse events related to the device. Minimal urinary incontinence. [...]
The Vanquish® Water Vapor Ablation System has been cleared as a tool for the thermal ablation of targeted prostate tissue via a transurethral approach. The FDA has not evaluated the Vanquish System for the treatment of any disease, including prostate cancer, or evaluated the Vanquish System for any long-term prostate cancer treatment outcomes.
Federal law (USA) restricts this device to sale by or on the order of a physician.
Refer to the device User Manual for a list of contraindications, warnings, and cautions.
Training: Do not operate the Vanquish System without completing Francis Medical-provided physician training. Untrained operation of the device may lead to improper use. Improper use can result in patient injury or equipment malfunction.